08.13.22
MPO's top companies report is topping page views again.
For the second consecutive week, the magazine's annual ranking of the 30 top-grossing medtech companies drove the bulk of website traffic. The report provides a detailed review of each company's 2021 financial performance as well as key product introductions, personnel changes, acquisitions, lawsuits, and community service projects. Most of the companies on the list fared well last year as they recovered from various pandemic-induced setbacks (i.e., sales losses, dwindling elective surgery volume, tepid demand).
Nearshoring and medical device regulations also enticed cybervisitors to the website this past week. Readers favored Contributing Editor Mark Crawford's feature on nearshoring and WuXi AppTec Medical Device Testing's explanatory column on the regulatory pathway for medical devices and drug delivery systems. Crawford's article (in the July/August issue of the magazine) discusses the nearshoring trends impacting medtech manufacturing, and identifies both Mexico and Costa Rica as preferred nearshoring locations. "Having faced widespread supply chain disruptions over the past two years, manufacturers across the U.S. are increasingly sourcing components closer to home to bolster resilience and ensure product reliability," Crawford writes.
WuXi AppTec's column detailed the steps medtech manufacturers and drug sponsors can take to strengthen submissions, shorten timelines, improve testing outcomes, and support patient safety for combination products.
Other items of interest to MPO website vistors this past week included the U.K.'s plans to strengthen medical device regulations and Cardinal Health CEO Mike Kaufmann's decision to step down as of Sept. 1. Kaufmann did not give a reason for his departure; Chief Financial Officer (CFO) Jason Hollar will assume Kaufmann's position, while Patricia English—currently the chief accounting officer and senior VP—will serve as interim CFO.
For the second consecutive week, the magazine's annual ranking of the 30 top-grossing medtech companies drove the bulk of website traffic. The report provides a detailed review of each company's 2021 financial performance as well as key product introductions, personnel changes, acquisitions, lawsuits, and community service projects. Most of the companies on the list fared well last year as they recovered from various pandemic-induced setbacks (i.e., sales losses, dwindling elective surgery volume, tepid demand).
Nearshoring and medical device regulations also enticed cybervisitors to the website this past week. Readers favored Contributing Editor Mark Crawford's feature on nearshoring and WuXi AppTec Medical Device Testing's explanatory column on the regulatory pathway for medical devices and drug delivery systems. Crawford's article (in the July/August issue of the magazine) discusses the nearshoring trends impacting medtech manufacturing, and identifies both Mexico and Costa Rica as preferred nearshoring locations. "Having faced widespread supply chain disruptions over the past two years, manufacturers across the U.S. are increasingly sourcing components closer to home to bolster resilience and ensure product reliability," Crawford writes.
WuXi AppTec's column detailed the steps medtech manufacturers and drug sponsors can take to strengthen submissions, shorten timelines, improve testing outcomes, and support patient safety for combination products.
Other items of interest to MPO website vistors this past week included the U.K.'s plans to strengthen medical device regulations and Cardinal Health CEO Mike Kaufmann's decision to step down as of Sept. 1. Kaufmann did not give a reason for his departure; Chief Financial Officer (CFO) Jason Hollar will assume Kaufmann's position, while Patricia English—currently the chief accounting officer and senior VP—will serve as interim CFO.